iMetabolic Biopharma Corporation — Form C-AR (Regulation Crowdfunding)

iMetabolic Biopharma Corporation of Tempe, AZ filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2024-07-19.

Offering

• Filed: 2024-07-19
• Form: C-AR
• Accession: 0001665160-24-001088

Issuer

• CIK: 0001957114
• Website: https://imbiopharma.com/
• Legal status: Corporation
• Organized in: NV
• Incorporated: 2017-11-17
• Address: 2155 E Conference Dr, Tempe, AZ, 85284-2604
• Employees: 4

Financials (as filed)

• Total assets (most recent): $101K
• Cash (most recent): $101K
• Revenue (most recent): $77K
• Net income (most recent): $-201K
• Net income (prior): $-83K
• Short-term debt: $9K
• Long-term debt: $456K

People (4)

Reg CF filing history (8)

More

• CIK 1957114 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search